Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
WuXi Biologics
Biotech
Earendil pens $885M pact to use WuXi XDC's linker tech for ADCs
AI research biotech Earendil Labs penned an $885 million deal to use WuXi XDC’s linker-payload tech to create next-gen antibody-drug conjugates.
James Waldron
Feb 27, 2026 5:30am
Candid adds another T-cell engager via $925M WuXi Biologics deal
Jan 7, 2025 8:42am
BioNTech pays WuXi $20M for 2 preclinical monoclonal antibodies
Jan 11, 2024 9:23am
WuXi CRDMO spinoff WuXi XDC partners with IntoCell
Jan 3, 2024 11:05am
Mediar gets a spark from Pfizer's Ignite program
Oct 25, 2023 10:50am
GSK pays WuXi $40M for preclinical anti-cancer bispecific
Jan 5, 2023 5:45am
